The results showed higher concentrations of CCL4 in T2DM patients than in the controls (SMD=1.14; 95% CI: 0.51 - 1.78; Figure 1), but with significant heterogeneity (I2=94%). This evidence concerns the gene CCL4 and type 2 diabetes mellitus.